Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|October 30, 2015
miR-134 Modulates the Proliferation of Human Cardiomyocyte Progenitor Cells by Targeting Meis2Ya-Han Wu, Hong Zhao, Li-Ping Zhou, et al.
Nutrients|November 26, 2022
The Lignan-Rich Fraction from Sambucus williamsii Hance Exerts Bone Protective Effects via Altering Circulating Serotonin and Gut Microbiota in RatsHui-Hui Xiao, Yu-Xin Zhu, Lu Lu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 25, 2021
The lignan-rich fraction from Sambucus Williamsii Hance ameliorates dyslipidemia and insulin resistance and modulates gut microbiota composition in ovariectomized ratsHui-Hui Xiao, Lu Lu, Christina Chui-Wa Poon, et al.
Frontiers in Oncology|April 7, 2022
Effects of Stereotactic Body Radiation Therapy Plus PD-1 Inhibitors for Patients With Transarterial Chemoembolization RefractoryYan-Jun Xiang, Kang Wang, Yi-Tao Zheng, et al.
Cancer Medicine|March 31, 2023
Efficacy and safety of TACE combined with lenvatinib and PD-1 inhibitors for unresectable recurrent HCC: A multicenter, retrospective studyWei-Jun Wang, Zong-Han Liu, Kang Wang, et al.
Therapeutic Advances in Gastroenterology|April 3, 2023
Efficacy and safety of a triple combination of atezolizumab, bevacizumab plus GEMOX for advanced biliary tract cancer: a multicenter, single-arm, retrospective studyKang Wang, Zong-Han Liu, Hong-Ming Yu, et al.
Frontiers in Oncology|December 12, 2022
Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real worldJin-Kai Feng, Zong-Han Liu, Zhi-Gang Fu, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 10, 2022
Transarterial chemoembolization plus a PD-1 inhibitor with or without lenvatinib for intermediate-stage hepatocellular carcinomaYan-Jun Xiang, Kang Wang, Hong-Ming Yu, et al.
Translational Oncology|January 7, 2026
Induction chemotherapy with nedaplatin, docetaxel and 5-fluorouracil followed by concurrent nedaplatin and radiotherapy in locoregionally advanced nasopharyngeal carcinoma: A single arm, open label, phase II clinical trialFang-Zheng Chen, Ying Deng, Wen-Jing Yin, et al.
Molecules (Basel, Switzerland)|August 12, 2023
Identification of the Microbial Transformation Products of Secoisolariciresinol Using an Untargeted Metabolomics Approach and Evaluation of the Osteogenic Activities of the MetabolitesWen-Xuan Yu, Hok-Him Tang, Jun-Jie Ye, et al.
Pageof 9